Cargando…

Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones

Lysates of cultured cells have been analyzed for arginine-specific endoproteases using peptidyl-p-n itroanil ides as chromogenic substrates. The enzymes present in MDBK, MDCK, VERO, BHK, and chick embryo cells required lysinearginine or arginine-arginine pairs as cleavage sites, whereas chorioallant...

Descripción completa

Detalles Bibliográficos
Autores principales: Garten, Wolfgang, Stieneke, Andrea, Shaw, Elliott, Wikstrom, Peter, Klenk, Hans-Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173068/
https://www.ncbi.nlm.nih.gov/pubmed/2773317
http://dx.doi.org/10.1016/0042-6822(89)90103-7
_version_ 1783524380161081344
author Garten, Wolfgang
Stieneke, Andrea
Shaw, Elliott
Wikstrom, Peter
Klenk, Hans-Dieter
author_facet Garten, Wolfgang
Stieneke, Andrea
Shaw, Elliott
Wikstrom, Peter
Klenk, Hans-Dieter
author_sort Garten, Wolfgang
collection PubMed
description Lysates of cultured cells have been analyzed for arginine-specific endoproteases using peptidyl-p-n itroanil ides as chromogenic substrates. The enzymes present in MDBK, MDCK, VERO, BHK, and chick embryo cells required lysinearginine or arginine-arginine pairs as cleavage sites, whereas chorioallantoic membrane cells contained, in addition, an activity that could cleave at a single arginine. The effect of peptidyl chloroalkyl ketones on the activation of the fowl plague virus hemagglutinin by the proteases specific for paired basic residues has been investigated. When virions containing uncleaved hemagglutinin were incubated with lysates of uninfected cells, cleavage was completely inhibited by peptidyl chloroalkyl ketones containing paired basic residues at a concentration of 1 mM. In contrast a compound containing a single arginine had no inhibitory activity. When dibasic peptidyl chloroalkyl ketones were added to infected cell cultures, cleavage of hemagglutinin and multiple cycles of virus replication were inhibited at 10 mM. However, a 100-to 200-fold increase of the inhibitory activity in intact cells could be achieved by N-terminal acylation. These studies suggest a potential role of peptidyl chloroalkyl ketones as antiviral agents
format Online
Article
Text
id pubmed-7173068
institution National Center for Biotechnology Information
language English
publishDate 1989
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71730682020-04-22 Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones Garten, Wolfgang Stieneke, Andrea Shaw, Elliott Wikstrom, Peter Klenk, Hans-Dieter Virology Article Lysates of cultured cells have been analyzed for arginine-specific endoproteases using peptidyl-p-n itroanil ides as chromogenic substrates. The enzymes present in MDBK, MDCK, VERO, BHK, and chick embryo cells required lysinearginine or arginine-arginine pairs as cleavage sites, whereas chorioallantoic membrane cells contained, in addition, an activity that could cleave at a single arginine. The effect of peptidyl chloroalkyl ketones on the activation of the fowl plague virus hemagglutinin by the proteases specific for paired basic residues has been investigated. When virions containing uncleaved hemagglutinin were incubated with lysates of uninfected cells, cleavage was completely inhibited by peptidyl chloroalkyl ketones containing paired basic residues at a concentration of 1 mM. In contrast a compound containing a single arginine had no inhibitory activity. When dibasic peptidyl chloroalkyl ketones were added to infected cell cultures, cleavage of hemagglutinin and multiple cycles of virus replication were inhibited at 10 mM. However, a 100-to 200-fold increase of the inhibitory activity in intact cells could be achieved by N-terminal acylation. These studies suggest a potential role of peptidyl chloroalkyl ketones as antiviral agents Published by Elsevier Inc. 1989-09 2004-02-09 /pmc/articles/PMC7173068/ /pubmed/2773317 http://dx.doi.org/10.1016/0042-6822(89)90103-7 Text en Copyright © 1989 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Garten, Wolfgang
Stieneke, Andrea
Shaw, Elliott
Wikstrom, Peter
Klenk, Hans-Dieter
Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones
title Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones
title_full Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones
title_fullStr Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones
title_full_unstemmed Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones
title_short Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones
title_sort inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173068/
https://www.ncbi.nlm.nih.gov/pubmed/2773317
http://dx.doi.org/10.1016/0042-6822(89)90103-7
work_keys_str_mv AT gartenwolfgang inhibitionofproteolyticactivationofinfluenzavirushemagglutininbyspecificpeptidylchloroalkylketones
AT stienekeandrea inhibitionofproteolyticactivationofinfluenzavirushemagglutininbyspecificpeptidylchloroalkylketones
AT shawelliott inhibitionofproteolyticactivationofinfluenzavirushemagglutininbyspecificpeptidylchloroalkylketones
AT wikstrompeter inhibitionofproteolyticactivationofinfluenzavirushemagglutininbyspecificpeptidylchloroalkylketones
AT klenkhansdieter inhibitionofproteolyticactivationofinfluenzavirushemagglutininbyspecificpeptidylchloroalkylketones